Cardiac Science Aims To Recoup Japan Losses With Biphasic AEDs
This article was originally published in The Gray Sheet
Executive Summary
Cardiac Science expects to regain share of the Japanese automatic external defibrillator market with the launch of its biphasic AEDs in Japan, according to CEO Raymond Cohen
You may also be interested in...
Supporting Japan Applications With U.S. Data Is Slower, But Worth It – AGA
AGA Medical will support its second regulatory application in Japan with U.S. data - despite the Japanese health ministry's preference for domestic data - because Japanese trials are prohibitively expensive, according to CEO Franck Gougeon
Cardiac Science To Challenge Philips As Sole Biphasic AED Player In Japan
Cardiac Science anticipates receiving approval from the Japanese Ministry of Health, Labour & Welfare for a biphasic automated external defibrillator by the end of Q2, the firm says
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”